American Vanguard (NYSE:AVD) Downgraded by Zacks Investment Research to Sell

American Vanguard (NYSE:AVD) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Friday, Zacks.com reports.

According to Zacks, “American Vanguard Corporation is a diversified specialty and agricultural products company focusing on crop protection, turf and ornamental markets, and public health applications. The Company has continued its successful strategy of acquiring or licensing both new and well-established product lines that serve numerous high valued market niches. New product development and international expansion also provide an additional stimulus for growth. Through skilful marketing, diligent product registration, quality manufacturing, American Vanguard has positioned itself to capitalize on developing trends in modern agriculture. American Vanguard continues to meet the needs of a world demanding ever-increasing quantities of agricultural products for human food, animal feed, natural fibers and alternative fuels. “

Separately, ValuEngine upgraded American Vanguard from a “sell” rating to a “hold” rating in a report on Tuesday, September 10th.

American Vanguard stock opened at $13.52 on Friday. The stock has a market capitalization of $405.58 million, a price-to-earnings ratio of 16.69 and a beta of 1.34. American Vanguard has a 52-week low of $12.69 and a 52-week high of $21.19. The stock’s 50 day moving average price is $15.31 and its two-hundred day moving average price is $14.95. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.16 and a current ratio of 2.65.

American Vanguard (NYSE:AVD) last posted its quarterly earnings results on Tuesday, August 6th. The basic materials company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $109.83 million. American Vanguard had a return on equity of 6.34% and a net margin of 4.60%. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.19 EPS. On average, equities research analysts forecast that American Vanguard will post 0.47 EPS for the current year.

In other news, CEO Eric G. Wintemute bought 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The shares were bought at an average cost of $14.08 per share, for a total transaction of $70,400.00. Following the acquisition, the chief executive officer now directly owns 955,060 shares in the company, valued at $13,447,244.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Ulrich Trogele bought 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was purchased at an average price of $14.24 per share, for a total transaction of $28,480.00. Following the completion of the acquisition, the chief operating officer now owns 126,201 shares in the company, valued at $1,797,102.24. The disclosure for this purchase can be found here. Insiders have acquired a total of 7,700 shares of company stock worth $109,050 over the last 90 days. Company insiders own 5.30% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the stock. Grantham Mayo Van Otterloo & Co. LLC lifted its holdings in shares of American Vanguard by 55.9% in the 2nd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 53,000 shares of the basic materials company’s stock worth $817,000 after purchasing an additional 19,000 shares in the last quarter. Atria Investments LLC lifted its holdings in shares of American Vanguard by 65.8% in the 2nd quarter. Atria Investments LLC now owns 32,226 shares of the basic materials company’s stock worth $6,122,000 after purchasing an additional 12,786 shares in the last quarter. Citadel Advisors LLC lifted its holdings in shares of American Vanguard by 35.2% in the 2nd quarter. Citadel Advisors LLC now owns 71,473 shares of the basic materials company’s stock worth $1,102,000 after purchasing an additional 18,618 shares in the last quarter. Paloma Partners Management Co bought a new position in shares of American Vanguard in the 2nd quarter worth $180,000. Finally, Marshall Wace LLP bought a new position in shares of American Vanguard in the 2nd quarter worth $194,000. Institutional investors own 75.84% of the company’s stock.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Further Reading: How to find the components of the quick ratio

Get a free copy of the Zacks research report on American Vanguard (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.